|
PSYCHIATRIC COFACTORS FOR
SMOKING
Overview
As
intensifying public health campaigns and workplace
smoking restrictions have led many casual or
"discretionary" smokers to stop smoking,
evidence is mounting that individuals who continue
to smoke are more likely than nonsmokers to
have subclinical or diagnosable psychopathology,
or even a history of psychopathology, that may
make smoking more rewarding or increase the
difficulty of quitting (Glassman, 1993; Pomerleau,
1997). Significantly higher smoking rates were
reported by Hughes and colleagues (1986) in
a sample of 217 psychiatric outpatients in comparison
with controls, a finding that has subsequently
been replicated in numerous reports. The best
documented of these smoking-linked co-morbid
conditions is depression, an association that
persists even after alcoholism and anxiety disorders
are factored out (Glassman, 1993). Other conditions
known or suspected to be over-represented in
smokers, and vice versa, include bulimia, binge
eating, and body image disturbances (Weiss &
Ebert, 1983; Killen et al., 1986; Bulik et al.,
1992; Krahn et al., 1992; Pomerleau & Krahn,
1993), anxiety (Breslau et al., 1991), attention
deficit-hyperactivity disorder (Borland &
Heckman, 1976; Hartsough & Lambert, 1987;
Barkley,1990; Pomerleau et al., 1995), and schizophrenia
(O'Farrell et al. 1983; Masterson & O'Shea,
1984; Goff et al., 1992), as well as alcohol
and other drug use (Istvan & Matarazzo,
1984; Bobo, 1989; Breslau et al., 1991). These
conditions constitute major public health problems
in their own right, taking a large toll in terms
of lost productivity and diminished quality
of life. To the extent that they are associated
with an increased likelihood of smoking or greater
difficulty in quitting, their health consequences
are magnified.
Summary
1)
Considerable evidence has been accumulated documenting
the overrepresentation of diagnosable or sub-clinical
psychiatric disorders among smokers, and vice
versa. The best documented of these cofactors
is depression. Others include anxiety disorders,
eating disorders such as binge-eating disorder
and bulimia nervosa, attention deficit disorder,
schizophrenia, and alcoholism. As the prevalence
of smoking declines, the association of smoking
and psychiatric disorders is likely to become
even stronger.
2)
Although the epidemiological association of
smoking with several psychiatric disorders has
been well documented, the mechanisms underlying
this association are not fully understood. It
is possible that in people with a history of
relevant psychiatric disorders, smoking cessation
"unmasks" behavioral or cognitive
deficits that, once expressed, are sustained
well beyond the usual manifestations of nicotine
withdrawal. Thus, dosing with nicotine in such
individuals would be expected to relieve both
nicotine withdrawal and psychiatric symptomatology.
Alternatively, smoking may predispose to psychiatric
disorders; or the relationship between smoking
and other drug use may represent common addictive
processes and/or drug interactions that are
pleasurable or reinforcing. Since depression
is frequently co-morbid with all of the other
conditions described, the possible mediating
role of depression in the link between these
conditions and smoking must also be considered.
3)
Although treating the cofactor in conjunction
with or prior to smoking cessation has face
validity, it is not known whether such a strategy
will facilitate smoking cessation, nor what
sequence of interventions is most likely to
produce favorable results.
4)
Smoking may enable people who might otherwise
require psychiatric intervention to manage symptomatology
or suboptimal functioning successfully. Research
is therefore needed to help in identifying individuals
who, though not symptomatic while smoking, may
be vulnerable to the emergence of depressive
episodes, disordered eating, or other psychopathology
following cessation.
References
Barkley
RA (1990). Attention Deficit Hyperactivity Disorders:
A handbook for diagnosis and treatment. New
York: Guilford Press.
Bobo
JK (1989). Nicotine dependence and alcoholism
epidemiology and treatment. Journal of Psychoactive
Drugs 21:323-329.
Borland
BL, Heckman HK (1976). Hyperactive boys and
their brothers: A 25-year follow-up study. Archives
of General Psychiatry 33:669-675.
Breslau
N, Kilbey MM, Andreski P (1991). Nicotine dependence,
major depression, and anxiety in young adults.
Archives of General Psychiatry 48:1069-1074.
Bulik
CM, Sullivan PF, Epstein LH, McKee M, Kaye WH,
Dahl RE, Weltzin TE (1992). Drug use in women
with anorexia and bulimia nervosa. International
Journal of Eating Disorders 11:213-225.
Glassman
AH (1993). Cigarette smoking: Implications for
psychiatric illness. American Journal of Psychiatry
150:546-553.
Goff
DC, Henderson DC, Amico E (1992). Cigarette
smoking in schizophrenia: Relationship to psychopathology
and medication side effects. American Journal
of Psychiatry 149:1189-1194.
Hartsough
CS, Lambert NM (1987). Pattern and progression
of drug use among hyperactives and controls:
A prospective short-term longitudinal study.
Journal of Child Psychology and Psychiatry 28:543-553.
Hughes
JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986).
Prevalence of smoking among psychiatric outpatients.
American Journal of Psychiatry 143:993-997.
Istvan
J, Matarazzo JD (1984). Tobacco, alcohol, and
caffeine use: A review of their interrelationships.
Psychological Bulletin 95:301-326.
Killen
JD, Taylor CB, Telch MJ, Robinson TN, Maron
DJ, Saylor KE (1986). Self-induced vomiting
and laxative and diuretic use among teenagers:
Precursors of the binge-purge syndrome? Journal
of the American Medical Assocation 255:1447-1449.
Krahn
D, Kurth C, Demitrack M, Drewnowski A (1992).
The relationship of dieting severity and bulimic
behaviors to alcohol and other drug use in young
women. Journal of Substance Abuse 4:341-353.
Masterson
F, O'Shea B (1984). Smoking and malignancy in
schizophrenia. British Journal of Psychiatry
145:429-432.
O'Farrell
TJ, Connors GJ, Upper D (1983). Addictive behaviors
among hospitalized psychiatric patients. Addictive
Behaviors 8:329-333.
Pomerleau
CS (1997). Cofactors for smoking and evolutionary
psychobiology. Addiction 92:397-408.
Pomerleau
CS, Krahn DD (1993). Smoking and eating disorders:
A connection? [abstract] Journal of Addictive
Diseases 12:169.
Pomerleau
OF, Downey KK, Stelson FW, Pomerleau CS (1995).
Cigarette smoking in adult patients diagnosed
with Attention Deficit Hyperactivity Disorder.
Journal of Substance Abuse 7:373-378.
Weiss
SR, Ebert MH (1983). Psychological and behavioral
characteristics of normal-weight bulimics and
normal-weight controls. Psychosomatic Medicine
45:293-303.
Back
to Psychiatric Cofactors for Smoking | Back
to Lines of Research
|